Centerline Biomedical

Centerline Biomedical

3D surgical navigation and positioning system

Overview

Centerline Biomedical develops intraoperative surgical navigation technology from the Cleveland Clinic lineage. Its flagship Intra Operative Positioning System (IOPS) is a 3D GPS-like system that provides real-time guidance by tracking instruments and anatomy to display a three-dimensional view during endovascular procedures, reducing radiation exposure and helping surgeons perform complex steps more accurately. The company differentiates itself with its Cleveland Clinic origins, a focus on intraoperative 3D navigation for endovascular surgery, and a model that combines direct sales, licenses, and ongoing support and training. Its goal is to improve surgical precision and safety while integrating into current operating room workflows to shorten procedures when possible.

About Centerline Biomedical

Simplify's Rating
Why Centerline Biomedical is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Robotics & Automation

Enterprise Software

Healthcare

Company Size

11-50

Company Stage

Series B

Total Funding

$46.2M

Headquarters

Warrensville Heights, Ohio

Founded

2014

Get referred to Centerline Biomedical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • March 11, 2025 FDA expansion opened neuro-endovascular and broader vascular markets.
  • August 2025 Jim Dillon hire strengthens commercialization after the 2024-2025 product launches.
  • 2025 Viewpoint Catheters and the ORSIF partnership reinforce radiation-safety differentiation.

What critics are saying

  • July 2025 recall allegations around IOPS Guidewire ATW-2 threaten trust and hospital adoption.
  • Centerline still needs repeated procedure wins beyond UVA to justify commercial traction.
  • The August 18, 2025 CEO change signals execution pressure after years of slow scaling.

What makes Centerline Biomedical unique

  • IOPS gives real-time 3D catheter guidance, reducing fluoroscopy dependence in endovascular procedures.
  • March 11, 2025 FDA cleared expanded IOPS indications into peripheral, aortic, and side-branch vasculature.
  • November 19, 2024 UVA completed the first on-label 6Fr Viewpoint Catheter case.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$46.2M

Above

Industry Average

Funded Over

4 Rounds

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Meet Average

Industry standards

$35M
$33M
Centerline Biomedical
$45M
Linktree
$65M
Substack
$100M
ClickUp

Growth & Insights and Company News

Headcount

6 month growth

↓ -2%

1 year growth

↓ -5%

2 year growth

↑ 0%
Yahoo Finance
Aug 18th, 2025
Centerline Biomedical Appoints Jim Dillon President and Chief Executive Officer

CLEVELAND, August 18, 2025-(BUSINESS WIRE)-Centerline Biomedical, Inc. ("Centerline"), an innovative leader in cardiovascular navigation and visualization systems, announced the appointment of Jim Dillon as President and Chief Executive Officer (CEO) and a member of its board of directors.

PR Newswire
Mar 4th, 2025
JumpStart Ventures Raises $25M for Fund III

JumpStart Ventures announced the first close of NEXT Fund III, raising nearly $25 million towards a $50 million target. Supported by SSBCI Ohio and other investors, the fund will invest in Seed and Series A startups. This marks JumpStart's third NEXT model fund and eighth overall, aiming to invest in about 15 startups. The firm has over $200 million under management and has seen successful exits from companies like CoverMyMeds and CardioInsight.

PR Newswire
Nov 19th, 2024
Centerline Biomedical Celebrates First On-Label Surgical Case At The University Of Virginia Health System With The 6Fr Viewpoint™ Catheter

CLEVELAND, Nov. 19, 2024 /PRNewswire/ -- Centerline Biomedical, Inc. ("Centerline"), an innovation leader in cardiovascular navigation and visualization systems, announced today the first on-label use of the 6Fr Viewpoint Catheter as part of the IOPS® platform. The procedure was performed at the University of Virginia Health System by Dr. Behzad Farivar. As stated by Dr

PR Newswire
Aug 6th, 2024
Centerline Biomedical Receives Fda 510(K) Clearance For New Iops® Viewpoint Catheter, Further Addressing Market Need To Reduce Physician Exposure To Harmful X-Ray Radiation During Image-Guided, Endovascular Procedures

CLEVELAND, Aug. 6, 2024 /PRNewswire/ -- Centerline Biomedical, Inc. ("Centerline"), an innovation leader in cardiovascular navigation and visualization systems, announced today that the IOPS Viewpoint Catheter has received US Food and Drug Administration (FDA) 510(k) clearance. The Viewpoint Catheter is the most recent addition to the company's patented IOPS (Intra-Operative Positioning System) portfolio.Viewpoint Catheter, a low profile 6 French (Fr) catheter available in multiple tip shapes and lengths, is designed for precision access to provide three-dimensional (3D) navigation feedback to clinicians. When Viewpoint Catheters are used in combination with the proprietary algorithms of the IOPS software, clinicians can clearly visualize endovascular tools in real-time and reduce their dependency on fluoroscopy systems. The result is state of the art image-guided, real-time navigation designed to revolutionize the way endovascular procedures are performed

PR Newswire
Jul 9th, 2024
Centerline Biomedical Joins Orsif

Centerline Biomedical and ORSIF join together to raise awareness of health risks associated with fluoroscopic radiation and solutions available to medical professionals.CLEVELAND, July 9, 2024 /PRNewswire/ -- Centerline Biomedical, Inc. ("Centerline"), joins ORSIF, the organization for Occupational Radiation Safety in International Fluoroscopy, to raise awareness of technology options to improve safety in the work environment where fluoroscopic x-ray radiation is used in medical procedures. As a corporate partner, Centerline supports ORSIF (www.orsif.org) in a shared mission to champion innovation for safer healthcare. In addition, the developing platform aims to continue bringing together healthcare providers and their organizations, professional medical societies, and industry to provide education on radiation safety."We are proud to join ORSIF in its mission to create greater awareness in the medical community regarding the dangers of radiation exposure and to protect those who commit their lives to the wellness of others. To that end, IOPS® (Intra-Operative Positioning System) technology enables improved visualization with 3D navigation in endovascular procedures while minimizing the reliance on damaging radiation," said Gulam Khan, CEO of Centerline Biomedical. "Employees at Centerline are inspired every day to design the future of image guidance technology that enables faster, more precise transcatheter procedures while reducing the use of radiation."Designed to mitigate radiation exposure during minimally invasive cardiovascular procedures, Centerline Biomedical IOPS (Intra-Operative Positioning System) is a novel technology gaining increased application in the US

Recently Posted Jobs

Sign up to get curated job recommendations

Centerline Biomedical is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →